Peking University First Hospital: Prostatic Neoplasms trials

The registry lists 21 Prostatic Neoplasms studies with Peking University First Hospital as lead sponsor. 16 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 2No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radioactive Counts From PSMA PET/CT-Targeted Biopsy Specimens for Real-time Diagnosis of Prostate Cancer: A Prospective StudyNot yet recruitingNCT07709403
• Comparison of TB+PB and TB+6SB for Prostate Cancer DiagnosisRecruitingNCT07460843Not applicable
• Sequential bpMRI for Suspicious Prostate LesionsNot yet recruitingNCT07332832
• Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of BeijingRecruitingNCT07319923
• Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019Not yet recruitingNCT07282197Phase 2
• Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate CancerRecruitingNCT07015138Not applicable
• Adjuvant Chemotherapy for High Malignant Prostate CancerRecruitingNCT06864533
• The Development and Validation of MRI-AI-based Predictive Models for csPCaRecruitingNCT06842264
• Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible LesionsRecruitingNCT06841211Not applicable
• Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate CancerRecruitingNCT06684652Not applicable
• Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）Not yet recruitingNCT06546527Early Phase 1
• The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence RecoveryRecruitingNCT06543420Not applicable
• Evaluation of Perilesional Biopsy in Diagnosis of Prostate CancerRecruitingNCT06482645Not applicable
• Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer DiagnosisRecruitingNCT06392737Not applicable
• A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate CancerRecruitingNCT06029036Phase 2
• Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical ProstatectomyNot yet recruitingNCT05576766Not applicable
• Clinically Actionable Tumor-Associated Antigens in Prostate CancerActive, not recruitingNCT07597369
• The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate CancerActive, not recruitingNCT06824259Not applicable
• Comprehensive Evaluation of MRI-AI in Prostate Cancer DiagnosisCompletedNCT06575361Not applicable
• Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate CancerCompletedNCT06482658Not applicable
• Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled TrialCompletedNCT06362291Not applicable